Results for: 'beauty'

After all, Molly-Mae did it. And against a backdrop of botched procedures and a pandemic-fuelled return to natural beauty, it would seem many others are following in the influencer’s direction. THE FACE explores whether or not tweakment reversal could be the next big thing.

Thanks to brands like Jacamo, ASOS and Rihanna’s Savage x Fenty, big and tall men are finally having their moment in the spotlight, taking the leap from the high street to high fashion. Here’s why the tide is finally turning.

The Beautystack boss and WAH Nails founder reveals her brand new app today, with a view to give women in all fields a leg up to achieve anything they put their mind to.

Instagram-surrealism, Jeffrey Campbell Litas, custom-made drugs and finding new ways to entertain ourselves: our favourite Substack writers more weigh in on the future of everything.

Here’s what Tyler, the Creator, SZA, Alessandra Garcia, Maggie Rogers, JaQuel Knight, Blondey McCoy, DeAndre Hopkins, Isabela Rangel, Helen Williams and Dr Dipen J Parekh have to say about the Williams' new label.

With 2021 almost out the door, the platform celebrates this year’s top talent, from trainspotter Francis Bourgeois and music sensation PinkPantheress, to disability rights activist Shelby Lynch.

Meet the actors, musicians, and designers looking to leave their mark this year.

Episode 2: Now that our favourite show is back on the airwaves, we've trawled the internet to find out where you can buy each character’s most memorable get-up, look-by-look.

My Media Diet: In her debut novel, Allie Rowbottom unpicks what longing for synthetic beauty can do to a person’s psyche. Here’s what the author – who’s well acquainted with Instagram’s dark underbelly – gets up to online.

We had a 10-minute chat with the actor about the pitfalls of fame and Francis Ford Coppola’s Megalopolis.

Oscar-nominated doc All the Beauty and the Bloodshed is a potent portrayal of loss and addiction, following the artist’s fight against deadly inequality, corporate greed and big pharma, writes Amelia Abraham.